About Us
Premium Insights
Expert Views
Compliance
Experts
Careers
Contact Us
Our Expert Views content provides the ideal narrative for businesses, subject matter experts, and those interested in the expert network industry's latest trends and talking points. These in-depth perspectives cover various industries, business verticals, sectors, and regions, supporting our global clientele.
Executive Director (Mar 2022 – Present); Uganda
This article examines digital health adoption in Uganda, private sector and PPP roles, AI integration, evolving healthcare models, sustainability initiatives, and key investor considerations for impactful, equitable healthcare innovation.
Chairman (Research, Innovation and International Relations) (Apr 2025 – Present); India
The article examines advancements in nuclear fusion for healthcare, focusing on medical isotope production, market trends, AI integration, major players’ strategies, and implications for India’s medical tourism and investment landscape.
Independent Director (Sep 2024 – Present); India
Explore India’s pharma evolution: AI-driven drug development, CRDMO market growth, domestic sourcing, public-private innovation, top revenue segments, and investor priorities shaping the industry’s future.
Independent Director (Sep 2024 – Present); India
The article explores AI-driven innovation, regulatory challenges, investment trends, and growth prospects in India's pharmaceutical sector, highlighting opportunities in biologics, manufacturing, and public-private partnerships.
Associate Vice President - Supply Chain Management (Apr 2014 – Present); India
The article discusses evolving pharmaceutical supply chains, AI-driven partnerships, sustainability initiatives, cold chain growth, cybersecurity measures, and key investment considerations shaping India’s pharmaceutical industry.
Chief Executive Officer (Apr 2021 – Present); UK
This article explores the evolving pharmaceutical landscape, highlighting innovation, digital transformation, patient-centric strategies, market growth drivers, and the global shift toward advanced therapies and responsible healthcare leadership.